Skip to main content
Clinical Trials/NL-OMON55660
NL-OMON55660
Completed
Not Applicable

TSPO PET tracing In patients with and without Cognitive impairment in the long-term after AneurySmal Subarachnoid haemorrhage - PICASSO

niversitair Medisch Centrum Utrecht0 sites36 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
aneurysmal subarachnoid hemorrhage (aSAH)
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
36
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • Subjects (n \= 14\) with aSAH \>3 years ago and cognitive impairment
  • \- Admitted to the UMCU with aneurysmal SAH at least 3 years ago, defined as
  • o Blood on initial non\-contrast CT or bilirubin in cerebrospinal fluid (CSF)
  • o A proven aneurysm, demonstrated by computed tomography angiography (CTA),
  • digital subtraction angiography (DSA) or magnetic resonance angiography (MRA)
  • \- Genotyping of rs6971 must show that patient is a high affinity binder
  • \- Functional independence (defined as modified rankin scale (mRS) or 0\-2\)
  • o mRS (Dutch) table can be found in Appendix 1
  • \- Patient must have been at least 18 years of age at time of visit to the
  • outpatient clinic.

Exclusion Criteria

  • \- Contra\-indication for PET\-MRI scanning (such as severe lower back pain or
  • claustrophobia)
  • \- Pregnancy
  • \- Exposure to ionic radiation (clinical or experimental) in the past year

Outcomes

Primary Outcomes

Not specified